Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib vs Sunitinib in Advanced Renal Cell Carcinoma
NCT00720941Phase 3Completed
- Sponsor
- Novartis
- Start
- Aug 2008
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 3 trial of pazopanib in renal cell carcinoma (RCC), sponsored by Novartis. Started Aug 2008; status: completed.
02
Drugs
pazopanib
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00720941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00720941.